Nexus Pharmaceuticals is a U.S.-based healthcare company specializing in innovative processes that make difficult-to-manufacture specialty and generic drugs easier to use, less labor intensive and more streamlined in practice.
Nexus ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they are needed most.
Since its inception in 2003, Nexus has been a pioneer in the generic drug industry. The fast-growing company has a robust pipeline featuring several recent launches of first-to-market, FDA-approved generic drugs.
Nexus is headquartered in Lincolnshire (IL), which houses the company’s state-of-the-art research and development laboratory. Nexus has nine FDA-approved lifesaving medications and six commercially available generic injectables trusted in 2,500 hospitals and health care facilities across the U.S.
For more information, visit the company’s website: www.nexuspharma.net